Примери за използване на A previous history на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
A previous history of Neuroleptic Malignant Syndrome(NMS) and/ or non-traumatic.
Particular attention should be given to patients with a previous history of allergic reactions.
If you have a previous history of Neuroleptic Malignant Syndrome Symptom Complex(NMS).
This may occur in people with or without a previous history of epilepsy or convulsions.
Levoff has also had a previous history of similar practice after trading in Apple's nonpublic information in 2011 and 2012 at least three more times.".
Хората също превеждат
Other clinical indicators, such as a previous history of self-harm, are also recognised as being associated with a heightened risk of suicide.
Caution should be exercised in patients being treated with Benepali who have a previous history of blood dyscrasias.
Levoff also had a previous history of insider trading, having traded on Apple's material nonpublic information at least three additional times in 2011 and 2012.
Caution should be exercised in patients being treated with LIFMIOR who have a previous history of blood dyscrasias.
The regulator also said Levoff had a previous history of insider trading, having traded on Apple's material nonpublic information at least three times in 2011 and 2012.
Patients with a history of reactions to contrast agents,including a previous history of reaction to iodine-based contrast agents.
Patients with a previous history of a depressive illness and/or suicide attempt should be monitored especially carefully for the emergence of depressive symptoms while taking sodium oxybate.
You had any reactions to previous injections of a contrast agent,including a previous history of reaction to iodine-based contrast agents.
Pregnant women with a previous history of herpes simplex virus type 1(HSV-1) infection maintain active antibodies against the virus, and researchers have found that this protection can pass to the nervous systems of their offspring.
To reduce the risk of NMS,Tasmar should not be prescribed for patients with severe dyskinesia or a previous history of NMS including rhabdomyolysis or.
Patients with a previous history of gastrointestinal disease including patients with peptic ulcer without recent bleeding or hospitalisation, and patients with dyspepsia or reflux controlled by medication were included in the once monthly treatment study.
Cases of atrial fibrillation and atrial flutter have been reported particularly in patients with cardiac risk factors, hypertension,acute infections, and a previous history of atrial fibrillation.
Irritant dermatitis is more common in atopics(often people with a previous history of atopic eczema), sensitive skin and other conditions in which skin barrier function is compromised.
Patients were excluded with a previous history of seizure, a condition that might predispose them to seizure, or certain prior treatments for prostate cancer(i.e., chemotherapy, ketoconazole, abiraterone acetate, aminoglutethimide and/or enzalutamide).
Before starting treatment:To reduce the risk of NMS, Tasmar should not be prescribed for patients with severe dyskinesia or a previous history of NMS including rhabdomyolysis or hyperthermia(see section 4.3).
Evidence of liver disease orincreased liver enzymes• Severe dyskinesia• A previous history of Neuroleptic Malignant Syndrome Symptom Complex(NMS) and/ or non- traumatic Rhabdomyolysis or Hyperthermia.• Hypersensitivity to tolcapone or any of its other ingredients.• Phaeochromocytoma.
The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisation series to very premature infants(born≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.
Immunogenicity in individuals previously vaccinated with live attenuated herpes zoster(HZ)vaccine In a phase III, open-label, multicentre clinical study(Zoster-048), a 2 dose schedule of Shingrix 2 months apart was assessed in 215 adults≥ 65 years of age with a previous history of vaccination with live attenuated HZ vaccine≥ 5 years earlier compared to 215 matched subjects who had never received live attenuated HZ vaccine.
The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisationseries to very premature infants(born≤28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.
The potential risk of apnoea and the need for respiratory monitoring for 48- 72h should be considered whenadministering to very premature infants(born≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.
The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisation seriesto very preterm infants(born≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.
The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisationseries to very premature infants(born 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.
The potential risk of apnoea and the need for respiratory monitoring for 48 to 72 hours should be considered when administering the primary immunisation series tovery premature infants(born≤ 28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity(see section 4.8).